Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Six Recurrent Amyloid-Related Imaging Abnormality Episodes in a Patient Treated With Aducanumab

Six Recurrent Amyloid-Related Imaging Abnormality Episodes in a Patient Treated With Aducanumab This case report describes a 67-year-old man with prodromal AD treated with aducanumab who developed amyloid-related imaging abnormality–vasogenic edema and –hemorrhage. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

Six Recurrent Amyloid-Related Imaging Abnormality Episodes in a Patient Treated With Aducanumab

Loading next page...
 
/lp/american-medical-association/six-recurrent-amyloid-related-imaging-abnormality-episodes-in-a-YTUj2kr6xw
Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/jamaneurol.2021.3933
Publisher site
See Article on Publisher Site

Abstract

This case report describes a 67-year-old man with prodromal AD treated with aducanumab who developed amyloid-related imaging abnormality–vasogenic edema and –hemorrhage.

Journal

JAMA NeurologyAmerican Medical Association

Published: Jan 8, 2022

References